This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Advenchen Pharmaceuticals, LLC. Active years: 2020.
Company Filing History:
Years Active: 2020
Title: The Innovative Contributions of Chen Monica
Introduction
Chen Monica is a notable inventor based in Moorpark, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target cancer-related diseases. His work is characterized by a commitment to advancing medical science through innovative solutions.
Latest Patents
Chen Monica holds a patent for "Fused quinoline compounds as PI3K/mTOR inhibitors." This invention relates to compounds that have the potential to inhibit mTor and PI3K, which are crucial in the treatment of various cancers associated with protein kinases. The patent outlines the processes for preparing these compounds, their pharmaceutical compositions, and their applications as medicaments in warm-blooded animals, including humans.
Career Highlights
Throughout his career, Chen Monica has been associated with Advenchen Pharmaceuticals, LLC, where he has played a pivotal role in research and development. His expertise in medicinal chemistry has contributed to the advancement of therapeutic options for cancer treatment.
Collaborations
Chen Monica has collaborated with esteemed colleagues such as Paul Chen Guoqing and Yan Changren. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new pharmaceutical solutions.
Conclusion
In summary, Chen Monica's contributions to the field of pharmaceuticals through his innovative patents and collaborative efforts highlight his dedication to improving cancer treatment options. His work continues to inspire advancements in medical research and development.